These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 17394649

  • 1. Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores.
    Kalabay L, Gráf L, Vörös K, Jakab L, Benko Z, Telegdy L, Fekete B, Prohászka Z, Füst G.
    BMC Gastroenterol; 2007 Mar 29; 7():15. PubMed ID: 17394649
    [Abstract] [Full Text] [Related]

  • 2. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T, Safka V, Hůlek P, Vanásek T, Krajina A, Jirkovský V.
    Vnitr Lek; 2006 Sep 29; 52(9):771-6. PubMed ID: 17091599
    [Abstract] [Full Text] [Related]

  • 3. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M.
    Eur J Clin Invest; 2009 Jan 29; 39(1):65-71. PubMed ID: 19087131
    [Abstract] [Full Text] [Related]

  • 4. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.
    Farnsworth N, Fagan SP, Berger DH, Awad SS.
    Am J Surg; 2004 Nov 29; 188(5):580-3. PubMed ID: 15546574
    [Abstract] [Full Text] [Related]

  • 5. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E, Botta F, Testa E, Romagnoli P, Polegato S, Malfatti F, Fumagalli A, Chiarbonello B, Risso D, Testa R.
    Am J Gastroenterol; 2002 Nov 29; 97(11):2855-60. PubMed ID: 12425560
    [Abstract] [Full Text] [Related]

  • 6. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD.
    J Clin Gastroenterol; 2007 Aug 29; 41(7):706-12. PubMed ID: 17667056
    [Abstract] [Full Text] [Related]

  • 7. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
    Bae WK, Lee JS, Kim NH, Kim KA, Moon YS, Oh MK.
    Korean J Hepatol; 2007 Mar 29; 13(1):51-60. PubMed ID: 17380075
    [Abstract] [Full Text] [Related]

  • 8. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R.
    Liver Int; 2004 Oct 29; 24(5):465-70. PubMed ID: 15482344
    [Abstract] [Full Text] [Related]

  • 9. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
    Brown DB, Fundakowski CE, Lisker-Melman M, Crippin JS, Pilgram TK, Chapman W, Darcy MD.
    J Vasc Interv Radiol; 2004 Nov 29; 15(11):1209-18. PubMed ID: 15525739
    [Abstract] [Full Text] [Related]

  • 10. Human fetuin/alpha2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer.
    Kalabay L, Jakab L, Prohászka Z, Füst G, Benkö Z, Telegdy L, Lörincz Z, Závodszky P, Arnaud P, Fekete B.
    Eur J Gastroenterol Hepatol; 2002 Apr 29; 14(4):389-94. PubMed ID: 11943951
    [Abstract] [Full Text] [Related]

  • 11. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit.
    Cholongitas E, Senzolo M, Patch D, Kwong K, Nikolopoulou V, Leandro G, Shaw S, Burroughs AK.
    Aliment Pharmacol Ther; 2006 Apr 01; 23(7):883-93. PubMed ID: 16573791
    [Abstract] [Full Text] [Related]

  • 12. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.
    Mishra P, Desai N, Alexander J, Singh DP, Sawant P.
    J Gastroenterol Hepatol; 2007 Aug 01; 22(8):1232-5. PubMed ID: 17688663
    [Abstract] [Full Text] [Related]

  • 13. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
    Sun QF, Ding JG, Xu DZ, Chen YP, Hong L, Ye ZY, Zheng MH, Fu RQ, Wu JG, Du QW, Chen W, Wang XF, Sheng JF.
    J Viral Hepat; 2009 Jul 01; 16(7):464-70. PubMed ID: 19413694
    [Abstract] [Full Text] [Related]

  • 14. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
    Schepke M, Roth F, Fimmers R, Brensing KA, Sudhop T, Schild HH, Sauerbruch T.
    Am J Gastroenterol; 2003 May 01; 98(5):1167-74. PubMed ID: 12809844
    [Abstract] [Full Text] [Related]

  • 15. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD.
    Dig Liver Dis; 2008 Nov 01; 40(11):882-9. PubMed ID: 18339595
    [Abstract] [Full Text] [Related]

  • 16. MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver.
    Shaikh S, Ghani H, Memon S, Baloch GH, Jaffery M, Shaikh K.
    J Coll Physicians Surg Pak; 2010 Jul 01; 20(7):432-5. PubMed ID: 20642940
    [Abstract] [Full Text] [Related]

  • 17. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX, Yan LN, Wang WT, Xu MQ, Yang JY.
    Transplant Proc; 2007 Jun 01; 39(5):1501-4. PubMed ID: 17580172
    [Abstract] [Full Text] [Related]

  • 18. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS, Lang R, He Q, Yang YJ, Zhao DF, Chen DZ.
    Hepatobiliary Pancreat Dis Int; 2009 Feb 01; 8(1):46-9. PubMed ID: 19208514
    [Abstract] [Full Text] [Related]

  • 19. [Impact of basal prolactin levels on the prevalence of complications and the prognosis of patients with liver cirrhosis].
    Koller T, Kollerová J, Huorka M, Hlavatý T, Payer J.
    Vnitr Lek; 2009 May 01; 55(5):468-73. PubMed ID: 19514612
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    J Hepatol; 2005 Jun 01; 42(6):826-32. PubMed ID: 15885353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.